DEEPAK NITRITE LTD.-$ - 506401 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information on loss of shares18-11-2021
18-11-2021
Earnings Call for Q2FY22 of Deepak Nitrite Ltd
Conference Call with Deepak Nitrite Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.29-10-2021
Deepak Nitrite Ltd - 506401 - Publications Of Unaudited Financial Results
Publications of Unaudited Financial Results28-10-2021
Deepak Nitrite shares down 25% in 2 weeks. A buy-on-dips opportunity?
Analysts say that in the short term, Deepak Nitrite shares could little correction and then consolidate but the long-term view is intact28-10-2021
Q2FY22 Quarterly Result Announced for Deepak Nitrite Ltd.
Highlights Revenues at Rs. 1,690 crore, up by 70% Y-o-Y EBITDA at Rs. 395 crore, higher by 41% Y-o-Y PAT, at Rs. 254 crore, rises 49% on a Y-o-Y basis Revenues at Rs. 3,224 crore, up by 93% Y-o-Y EBITDA at Rs. 855 crore, higher by 83% Y-o-Y PAT, at Rs. 557 crore, rises 107% on a Y-o-Y basis EPS of Rs. 40.84 per share, higher by 107% Y-o-Y Revenues were up 93% at Rs. 3,224 crore in H1 FY22 compared to Rs. 1,673 crore in H1 FY21. Overall, the Company has been highly responsive in order to optimise opportunities from the improved operating environment. In addition, the growth has been led by incremental gains in the BI SBU as well as the Phenolics business. EBITDA of Rs. 855 crore in H1 FY22 compared to Rs. 468 crore in H1 FY21, up by 83%. Extra The improved operating performance in the current year-to-date has driven EBITDA growth. EBITDA margin has been largely stable on a y-o-y basis at 27% in H1 FY22 despite unprecedented rise in input prices. PAT grew by 107% at Rs. 557 crore in H1 FY22 compared to Rs. 269 crore in H1 FY21. All functions of the Company have contributed towards attaining newer benchmark of profitability in the first half. EPS for H1 FY22 was Rs. 40.84 per share (of face value of Rs. 2 each) as compared to Rs. 19.73 per share in H1 FY21. Revenues were up 70% at Rs. 1,690 crore in Q2 FY22 compared to Rs. 991 crore in Q2 FY21. SBUs of BI, PP and Phenolics delivered scaled up performance during the quarter benefiting from operating leverage on account of better operating environment. The FSC segment delivered stable volumes according to business plan despite constraints to availability of inputs and challenges with respect to logistics. EBITDA was Rs. 395 crore in Q2 FY22 compared to Rs. 280 crore in Q2 FY21, higher by 41% on a y-o-y basis. The EBITDA Margin was 23% compared to 28% in the same quarter of corresponding year due to combination of higher input prices as well as increased cost of power and logistics PAT was Rs. 254 crore in Q2 FY22 compared to Rs. 170 crore in Q2 FY21, higher by 49%. In addition to the strong operational performance, PAT performance was enhanced by the reduction in finance costs. EPS for Q2 FY22 was Rs. 18.65 per share (of face value of Rs. 2 each) as compared to Rs. 12.48 per share in Q2 FY21. Commenting on the performance, Mr. Deepak C. Mehta, Chairman & Managing Director, said “I’m glad to see the best of DNL once again brought to the fore in the face of challenges ranging from COVID, raw material and freight fluctuation and energy costs. This is a testament to the kind of systems and people we have in place to deliver sustainable results. We are embarking on the next phase of our transformation into a diversified chemical company that has the dual capability to maintain its leadership position in its existing value chain while applying itself to innovative new platforms and products. I anticipate a deeper partnership between Deepak and its strategic customers as significant volumes of our current and future products are supplied as part of long term, formula linked arrangements. In the meanwhile, the company will continue to place a high degree of importance to the twin pillars of process intensification and operational excellence in a responsible and sustainable manner. Growth going forward will be driven by planned expansion initiatives across SBUs and tactical introduction of several downstream chemicals and complex chemical platforms. We remain focused on our agility enabling us to capitalise on opportunities that emerge from rapid shifts across the industry landscape. Our entry into newer solvents will diversify our product portfolio, expand our client base, and increase the percentage of complex, high-margin products in the mix, thereby enhancing our business proposition." Result PDF28-10-2021
DEEPAK NITRITE LTD.-$ - 506401 - Q2 & H1 FY2022 - INVESTOR COMMUNICATION
Q2 & H1 FY2022 - INVESTOR COMMUNICATION27-10-2021
DEEPAK NITRITE LTD.-$ - 506401 - Schedule Of Q2 & H1 FY2022 Earnings Conference Call
Schedule of Q2 & H1 FY2022 Earnings Conference Call27-10-2021
DEEPAK NITRITE LTD.-$ - 506401 - Un-Audited Financial Results For The Second Quarter And Half Year Ended 30Th September, 2021
Un-audited Financial Results for the Second Quarter and Half Year ended 30th September, 202127-10-2021
Deepak Nitrite Ltd - 506401 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation on loss of Shares Certificates27-10-2021